resveratrol has been researched along with benzonidazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferreira, ME; Gómez-Barrio, A; Heguaburu, V; Marrero-Ponce, Y; Montero-Torres, A; Nakayama, H; Pandolfi, E; Rojas de Arias, A; Roldos, V; Rolón, M; Sanabria, L; Torres, S; Trucco, F; Vega, C; Yaluff, G | 1 |
| Bottari, NB; da Silva, AD; da Silva, AS; Fracasso, M; Monteiro, SG; Reichert, K; Schetinger, MRC | 1 |
2 other study(ies) available for resveratrol and benzonidazole
| Article | Year |
|---|---|
Activity of a hydroxybibenzyl bryophyte constituent against Leishmania spp. and Trypanosoma cruzi: in silico, in vitro and in vivo activity studies.
Topics: Animals; Antiprotozoal Agents; Bibenzyls; Cattle; Cell Line; Computational Biology; Extracellular Space; Female; Inhibitory Concentration 50; Intracellular Space; Leishmania; Leishmaniasis; Male; Mice; Phenols; Trypanosoma cruzi | 2008 |
Involvement of ectonucleotidases and purinergic receptor expression during acute Chagas disease in the cortex of mice treated with resveratrol and benznidazole.
Topics: Acute Disease; Animals; Antioxidants; Cerebral Cortex; Chagas Disease; Female; Gene Expression; Immunosuppressive Agents; Mice; Nitroimidazoles; Oxidative Stress; Receptors, Purinergic; Resveratrol | 2021 |